Long-term outcomes in patients with advanced coronary artery disease are better than expected
Death rates associated with patients with refractory angina, or chronic chest pain, are lower than previously considered; therefore, physicians should focus on relieving the chest pain symptoms and improving the quality of ...
Cardiology
May 15, 2013 |
not rated yet |
0
World first clinical trial supports use of Kava to treat anxiety
(Medical Xpress)—A world-first completed clinical study by an Australian team has found Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering anxiety.
Psychology & Psychiatry
May 13, 2013 |
5 / 5 (2) |
1
Patients most annoyed by long waits, unclear test results
(HealthDay)—Long waiting times and unclear test results are the top patient grievances when it comes to visiting the doctor, according to a report published in the June issue of Consumer Reports.
Health
May 03, 2013 |
not rated yet |
0
Drug targets hard-to-reach leukemia stem cells responsible for relapses
Researchers at the University of California, San Diego School of Medicine have discovered that hard-to-reach, drug-resistant leukemia stem cells (LSCs) that overexpress multiple pro-survival protein forms ...
Cancer
Jan 17, 2013 |
3.7 / 5 (3) |
0
|
Researchers develop procedure for reducing fear response in sleeping mice
(Medical Xpress)—Researchers at Stanford University have developed a procedure that reduces a fear response in mice. It involves, team lead Asya Rolls said as she presented the groups' findings at this year's ...
Neuroscience
Oct 19, 2012 |
5 / 5 (1) |
1
|
The path to personalized cancer treatment
In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 Mar ...
Cancer
Mar 28, 2012 |
5 / 5 (2) |
0
|
Alternative medicine use by MS patients mapped
A major Nordic research project involving researchers from the University of Copenhagen has, for the first time ever, mapped the use of alternative treatment among multiple sclerosis patients - knowledge which is important ...
Diseases, Conditions, Syndromes
Apr 19, 2013 |
not rated yet |
0
Study shows mirabegron effective and well tolerated for overactive bladder
In a new phase III trial mirabegron, a β3-adrenoceptor agonist, given once daily for 12 weeks, reduced the frequency of incontinence episodes and number of daily urinations, and improved urgency and nocturia in adults with ...
Diseases, Conditions, Syndromes
Mar 04, 2013 |
not rated yet |
0
Research paves way for non drug-based dementia treatments for 'behaviors that challenge' carers
Alternative therapies for dementia patients need to be researched and applied more consistently if they are to help care organisations improve the well-being of patients and reduce the number of antipsychotic drugs prescribed.
Diseases, Conditions, Syndromes
Feb 15, 2012 |
4.5 / 5 (2) |
0
Can computers save health care? Research shows lower costs, better outcomes
New research from Indiana University has found that machine learning - the same computer science discipline that helped create voice recognition systems, self-driving cars, and credit card fraud detection ...
Health
Feb 11, 2013 |
5 / 5 (2) |
0
Resistance to first line anti-malarial drugs is increasing on the Thai-Myanmar border
Early diagnosis and treatment with antimalarial drugs (ACTs—artemisinin based combination treatments) has been linked to a reduction in malaria in the migrant population living on the Thai-Myanmar border, despite evidence ...
Diseases, Conditions, Syndromes
Mar 05, 2013 |
not rated yet |
0
|
Ganetespib shows potency against ALK-positive lung cancer and overcomes crizotinib resistance
A drug that indirectly impairs the function of several cancer-driving proteins, including anaplastic lymphoma kinase (ALK), may be an effective new treatment for patients with ALK—positive non-small cell lung cancer.
Cancer
Mar 26, 2013 |
not rated yet |
0
Chelation therapy doesn't alter quality of life in heart attack patients
Chelation therapy didn't change the ability to perform daily tasks or impact the emotional wellbeing of patients who previously suffered a heart attack, according to late-breaking clinical trial research presented at the ...
Cardiology
Nov 05, 2012 |
not rated yet |
0
Novel therapy helps ease pain and suffering for sickle cell patients
Chronic, debilitating pain and potential organ failure are what approximately 100,000 sickle cell patients in the United States live with each day. Yutaka Niihara, M.D., M.P.H. - lead investigator at The Los Angeles Biomedical ...
Diseases, Conditions, Syndromes
Sep 25, 2012 |
not rated yet |
0
Azathioprine may benefit pediatric atopic dermatitis
(HealthDay) -- For pediatric patients with refractory atopic dermatitis (AD), oral azathioprine is associated with clinical improvement, and measurement of thiopurine methyltransferase (TPMT) activity seems ...
Diseases, Conditions, Syndromes
Aug 21, 2012 |
not rated yet |
0
